ResMed R&D increased by 3.6% to $94.27M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.3%, from $83.94M to $94.27M. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 10.1% CAGR.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityStable
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
High spending signals a commitment to future growth and innovation, though it reduces current period earnings.
Detailed definition
Expenses related to the development of new products, services, and technologies, as well as the improvement of existing...
Peer comparison
Tech leaders often spend a significant percentage of revenue on R&D to prevent disruption by competitors.
Metric ID:
research_and_developmentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $59.88M | $59.95M | $62.51M | $66.80M | $64.32M | $63.19M | $69.87M | $76.44M | $78.14M | $75.71M | $73.88M | $77.07M | $80.86M | $79.52M | $81.37M | $83.94M | $86.44M | $87.32M | $90.97M | $94.27M |
| QoQ Change | — | +0.1% | +4.3% | +6.9% | -3.7% | -1.8% | +10.6% | +9.4% | +2.2% | -3.1% | -2.4% | +4.3% | +4.9% | -1.7% | +2.3% | +3.2% | +3.0% | +1.0% | +4.2% | +3.6% |
| YoY Change | — | — | — | — | +7.4% | +5.4% | +11.8% | +14.4% | +21.5% | +19.8% | +5.7% | +0.8% | +3.5% | +5.0% | +10.1% | +8.9% | +6.9% | +9.8% | +11.8% | +12.3% |
Range$59.88M – $94.27M
CAGR+10.0%
Avg YoY Growth+9.7%
Median YoY Growth+9.4%
Current Streak6 quarters growth
Business Segments
| Segment | Q1 '26 |
|---|---|
| Sleep And Breathing Health | $56.41M |
| Residential Care Software | $26.23M |
| Total | $94.27M |
R&D at Other Companies
Frequently Asked Questions
- What is ResMed's r&d?
- ResMed (RMD) reported r&d of $94.27M in Q1 2026.
- How has ResMed's r&d changed year-over-year?
- ResMed's r&d increased by 12.3% year-over-year, from $83.94M to $94.27M.
- What is the long-term trend for ResMed's r&d?
- Over 4 years (2021 to 2025), ResMed's r&d has grown at a 10.1% compound annual growth rate (CAGR), from $225.28M to $331.28M.
- What does r&d mean?
- The money spent on creating new technology and improving existing products.